Jubilant Pharmova Ltd

NSE: JUBLPHARMA BSE: 530019

₹1023.85

(0.12%)

Tue, 28 Jul 2026, 04:18 am

MTF 5xInvest in Jubilant Pharmova Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)16282.51

PE Ratio40.81

Dividend0.49

Health Technology

Pharmaceuticals: Major

24.5K

Jubilant Pharmova Ltd About

Jubilant Pharmova in radiopharma, allergy immunotherapy, contract development and manufacturing of sterile injectable, generics, contract research development and manufacturing and proprietary novel drugs businesses.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1978

Headquarters

CEO

Shyam S Bhartia

Employees

Contact

Website

http://www.jubl.com

investors@jubl.com

Phone

91-5924-267200

Location

Bhartiagram Gajraula, , Amroha, Uttar Pradesh, 244223

Executives

Shyam S Bhartia

Chairman (Non-Executive)

Hari S Bhartia

Co-Chairman

Vivek Mehra

Independent Director

SUSHIL KUMAR ROONGTA

Independent Director

Priyavrat Bhartia

Managing Director

Arjun Shanker Bhartia

Joint Managing Director

Arun Seth

Independent Director

Shirish Gundopant Belapure

Independent Director

Ramakrishnan Arul

Whole-time Director

Harsh Mahajan

Independent Director

Shivpriya Nanda

Independent Director

Arvind Chokhany

Whole Time Director

Naresh Kapoor.

Company Sec. & Compli. Officer